RxSight, Inc.
RXST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,816 | -$11,786 | -$8,190 | -$5,938 |
| Dep. & Amort. | $854 | $776 | $785 | $523 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,108 | $8,547 | $7,140 | $7,282 |
| Change in WC | $1,745 | -$1,013 | -$6,208 | -$3,570 |
| Other Non-Cash | -$2,078 | -$900 | -$2,359 | -$2,557 |
| Operating Cash Flow | -$1,187 | -$4,376 | -$8,832 | -$4,260 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$581 | -$1,537 | -$575 | -$847 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$68,423 | -$33,811 | -$38,570 | -$52,833 |
| Inv. Sales/Matur. | $60,000 | $50,000 | $60,000 | $55,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$9,004 | $14,652 | $20,855 | $1,320 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$19 | -$3 | -$13 | -$12 |
| Stock Issued | $131 | $2,068 | $696 | $2,988 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$642 | $0 | -$1,418 | $0 |
| Financing Cash Flow | -$530 | $2,065 | -$735 | $2,976 |
| Forex Effect | -$2 | $14 | $6 | -$50 |
| Net Chg. in Cash | -$10,723 | $12,355 | $11,294 | -$14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,105 | $28,750 | $17,456 | $17,431 |
| End Cash | $30,382 | $41,105 | $28,750 | $17,456 |
| Free Cash Flow | -$1,768 | -$5,913 | -$9,407 | -$5,107 |